Evidence map›Paper›PMID 35459656›Full record

ArticleBMJ case reports2022

Granulocyte colony-stimulating factor as a cause of acute leucocytoclastic vasculitis with anti-Ro and anti-La antibodies.

Antonio Ji-Xu, Liam Carroll, Thomas Bentley, Rachael Jarrett

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Antonio Ji-XuDepartment of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK ajixu@ucdavis.edu.ORCID http://orcid.org/0000-0003-4705-181X
Liam CarrollDepartment of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Thomas BentleyMedical Sciences Division, Oxford University, Oxford, UK.ORCID http://orcid.org/0000-0002-7124-4737
Rachael JarrettDepartment of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Oxford University Hospitals NHS Trust · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Granulocyte colony-stimulating factor (G-CSF) administration is associated with a diverse range of cutaneous sequelae. Serious dermatological side effects of G-CSF include the development of Sweet's syndrome and exacerbations of pre-existing inflammatory disorders such as psoriasis. Here, we describe a report of acute leucocytoclastic vasculitis caused by G-CSF therapy associated with anti-Ro and anti-La antibodies in a patient with multiple myeloma. This case highlights the importance of having a high index of suspicion for acute leucocytoclastic vasculitis in patients with haematological malignancies undergoing G-CSF therapy.

Indexed as

Sweet SyndromeVasculitis, Leukocytoclastic, CutaneousAntibodies, AntinuclearGranulocyte Colony-Stimulating FactorHumansSkinAntibodies, AntinuclearGranulocyte Colony-Stimulating FactorContraindications and precautionsDermatologyImmunologyMalignant and Benign haematologyOncology

Identifiers

PMID35459656
PMCPMC9036362
OpenAlexW4224309817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.